🇺🇸 MET in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised MET on 29 August 2005

Marketing authorisation

FDA — authorised 29 August 2005

Application: NDA021842
Marketing authorisation holder: TAKEDA PHARMS USA
Status: supplemented

Other Endocrinology / Diabetes approved in United States

Frequently asked questions

Is MET approved in United States?

Yes. FDA authorised it on 29 August 2005.

Who is the marketing authorisation holder for MET in United States?

TAKEDA PHARMS USA holds the US marketing authorisation.